<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08906092200057</udiDi>
    <basicUdiDi>890609220HAOSGV</basicUdiDi>
    <tradeName>08906092200057</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BIO-HYALUR EV</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:43:19.319Z</lastUpdated>
  </row>
  <row>
    <udiDi>08906092200255</udiDi>
    <basicUdiDi>890609220HAOSGV</basicUdiDi>
    <tradeName>08906092200255</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BIO-HYALUR SV</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:43:17.110Z</lastUpdated>
  </row>
  <row>
    <udiDi>08906092200408</udiDi>
    <basicUdiDi>890609220HAOSGV</basicUdiDi>
    <tradeName>08906092200408</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BIO-HYALUR DUO</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:43:03.906Z</lastUpdated>
  </row>
  <row>
    <udiDi>08906092200415</udiDi>
    <basicUdiDi>890609220HAOSGV</basicUdiDi>
    <tradeName>08906092200415</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BIO-HYALUR DUO</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:42:50.199Z</lastUpdated>
  </row>
  <row>
    <udiDi>08906092200422</udiDi>
    <basicUdiDi>890609220HAOSGV</basicUdiDi>
    <tradeName>08906092200422</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BIO-HYALUR DUO</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:41:10.320Z</lastUpdated>
  </row>
  <row>
    <udiDi>06936020103046</udiDi>
    <basicUdiDi>69360201088U</basicUdiDi>
    <tradeName>Singclean®</tradeName>
    <deviceName>Viscoelastic Solution for Ophthalmic Surgery</deviceName>
    <manufacturerName>Hangzhou Singclean Medical Products Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000014098</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>OPH-SC-15-0.5</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-02T07:04:39.398Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595532970</udiDi>
    <basicUdiDi>426059553MP03UD01JE</basicUdiDi>
    <tradeName>BLUpan® medical UD</tradeName>
    <deviceName>Sodium Hyaluronate - Dexpanthenol Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>41127200</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:53:34.840Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595532697</udiDi>
    <basicUdiDi>426059553MP44OSD012E</basicUdiDi>
    <tradeName>Visiodoron Malva® Intense</tradeName>
    <deviceName>Sodium Hyaluronate 0.3% - Malva Sylvestris Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41125400</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:53:33.234Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595532192</udiDi>
    <basicUdiDi>426059553MP18OSD012F</basicUdiDi>
    <tradeName>Visiodoron Malva®</tradeName>
    <deviceName>Sodium Hyaluronate 0.15% - Malva Sylvestris Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41112900</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:53:30.036Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595532147</udiDi>
    <basicUdiDi>426059553MP18UD01LJ</basicUdiDi>
    <tradeName>Visiodoron Malva® (Muster)</tradeName>
    <deviceName>Sodium Hyaluronate 0.15% - Malva Sylvestris Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41100700</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:53:28.431Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595531492</udiDi>
    <basicUdiDi>426059553MP27OSD012K</basicUdiDi>
    <tradeName>HYDRO med Blue</tradeName>
    <deviceName>Sodium Hyaluronate - Patent Blue V Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41117200</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:53:18.920Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595530976</udiDi>
    <basicUdiDi>426059553MP02UD01J3</basicUdiDi>
    <tradeName>BIOLAN® gel (Muster)</tradeName>
    <deviceName>Sodium Hyaluronate 0.3% Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41019200</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:53:15.748Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595530907</udiDi>
    <basicUdiDi>426059553MP25UD01KW</basicUdiDi>
    <tradeName>EyeMedica® Euphrasia Augentrost Augen-Tropfen SOS</tradeName>
    <deviceName>Sodium Hyaluronate - Euphrasia Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41128000</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:53:14.157Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595530860</udiDi>
    <basicUdiDi>426059553MP16OSD01ZJ</basicUdiDi>
    <tradeName>BIOLAN OSD kapi za oči</tradeName>
    <deviceName>Sodium Hyaluronate 0.15% Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>41065700</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:53:13.219Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595530648</udiDi>
    <basicUdiDi>426059553MP30OSD01Y6</basicUdiDi>
    <tradeName>EKTAL Sodium Hyaluronate 0,15 % - Ectoine Eye Drops</tradeName>
    <deviceName>Sodium Hyaluronate - Ectoine Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>41119900</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:53:08.425Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595530594</udiDi>
    <basicUdiDi>426059553MP01UD01HQ</basicUdiDi>
    <tradeName>bestview Augentropfen</tradeName>
    <deviceName>Sodium Hyaluronate 0.15% Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41085801</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:52:48.358Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595530464</udiDi>
    <basicUdiDi>426059553MP30UD01JL</basicUdiDi>
    <tradeName>HYDRO med Green</tradeName>
    <deviceName>Sodium Hyaluronate - Ectoine Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41118500</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:52:47.558Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595530426</udiDi>
    <basicUdiDi>426059553MP32OSD01YY</basicUdiDi>
    <tradeName>BLUpan® lipid plus OSD</tradeName>
    <deviceName>Sodium Hyaluronate - Dexpanthenol - Lipid Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>42014700</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:52:46.751Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595530358</udiDi>
    <basicUdiDi>426059553MP32UD01KA</basicUdiDi>
    <tradeName>BLUpan® lipid plus UD</tradeName>
    <deviceName>Sodium Hyaluronate - Dexpanthenol - Lipid Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>42014600</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:52:39.549Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595530259</udiDi>
    <basicUdiDi>426059553MP24UD01KK</basicUdiDi>
    <tradeName>BLUpan® medical UD</tradeName>
    <deviceName>Sodium Hyaluronate 0.15% - Dexpanthenol Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>42016200</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:52:33.146Z</lastUpdated>
  </row>
</eudamedExport>